Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults-Reference-Cited by-同舟云学术

Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults

Published:2023-11 Issue: Volume:131 Page:106-114
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Roccati Eddy^ORCID,Collins Jessica Marie,Bindoff Aidan David,Alty Jane Elizabeth,Bartlett Larissa,King Anna Elizabeth,Vickers James Clement

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference26 articles.

1. Alzheimer’s disease facts and figures;Alzheimer’s Association;Alzheimers Dement.,2018

2. Blood biomarkers from research use to clinical practice: what must be done? A report from the EU/US CTAD task force;Angioni;J. Prev. Alzheimers Dis.,2022

3. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease;Aschenbrenner;Neurology,2018

4. Plasma and CSF biomarkers in a memory clinic: head-to-head comparison of phosphorylated tau immunoassays;Ashton;Alzheimers,2022

5. Census data;Australian Bureau of Statistics,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults;Neurobiology of Aging;2024-06

2. Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum;BMC Neurology;2024-04-16

3. Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort;Frontiers in Aging Neuroscience;2024-02-07

4. Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum;2023-12-14